Filter Results :

Your search for Therapies returned 93 reports

Sort by


Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

01 Nov 2016  |  Published by:  GBI Research
SummaryHemophilia is a rare disease affecting more than 400,000 people worldwide. Hemophilia A is four times as common as hemophilia B, and more than half of patients with hemophilia A have a severe form of hemophilia. Males have a much higher chance of developing hemophilia because they only receiv...

$ 4,995.00

Read More

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

23 Sep 2016  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. It develops vitrogro, which is a synthetic scaffo...

$ 250.00

Read More

Global Allergy Immunotherapies Market Research Report 2016

16 Sep 2016  |  Published by:  9Dimen Research
2016 Global Allergy Immunotherapies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Allergy Immunotherapies industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Ja...

$ 2,850.00

Read More

Intra-Cellular Therapies, Inc. (ITCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

15 Sep 2016  |  Published by:  GlobalData
SummaryIntra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company that concentrates on the discovery and development of small molecule drugs to treat neuropsychiatric and neurologic disorders. The company's lead product candidate, ITI-007, which is intended for the treatment of schizophreni...

$ 250.00

Read More

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

13 Sep 2016  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. It develops vitrogro, which is a synthetic scaffo...

$ 250.00

Read More

Vital Therapies, Inc. (VTL) - Medical Equipment - Deals and Alliances Profile

13 Sep 2016  |  Published by:  GlobalData
SummaryVital Therapies, Inc. (Vital Therapies) is a bio therapeutic company that develops cell-based therapy treatment for liver failure. The company's clinical trials include VTI-206, VTI-208, VTI-210, VTI-201, VTIC-301, and VTI-212. Its product ELAD is a human cell based liver support system desig...

$ 250.00

Read More

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

01 Sep 2016  |  Published by:  GBI Research
SummaryGastric cancer is characterized by the formation of malignant cells in the inner lining of the stomach and is the fifth-most common cancer globally. There are many types of gastric cancer, but adenocarcinoma is the most common type and is diagnosed in 95% of cases. The life expectancy and sur...

$ 4,995.00

Read More

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

01 Sep 2016  |  Published by:  GBI Research
SummaryGlioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is the most common and aggressive human brain tumor, accounting for 15.4% of all primary brain tumors and 60-75% of all astrocytomas. It has a peak incidence between 55 and 84 years of age, with the median age o...

$ 6,995.00

Read More

Biotie Therapies Corp. (BTH1V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

24 Aug 2016  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as parkinson's disease, alzheimer's disease, pr...

$ 250.00

Read More

Biotie Therapies AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

24 Aug 2016  |  Published by:  GlobalData
SummaryBiotie Therapies AG (Biotie) is a specialized drug development company. It focuses on the development of products for neurodegenerative and psychiatric disorders such as Parkinson's disease, primary sclerosing cholangitis and others. The company’s lead product Selincro, is an orally administe...

$ 250.00

Read More

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

01 Aug 2016  |  Published by:  GBI Research
SummaryOphthalmology is a therapy area that deals with the diagnosis, treatment and prevention of diseases associated with the eyes and visual system. Most eye disorders occur over a long period of time, and are initially asymptomatic or cause only a slight decrease in vision. Howeve...

$ 4,995.00

Read More

Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes

01 Aug 2016  |  Published by:  GBI Research
SummaryPain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a growing body of evidence that substantiates chronic pain as a disease, rather than just as a symptom of a primary cause. In the US, p...

$ 6,995.00

Read More

Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way

01 Aug 2016  |  Published by:  GBI Research
SummaryThe respiratory therapy area consists of indications that affect the respiratory system in different ways, such as the scarring of lung tissue, and excessive production of mucus in the airways, thereby decreasing lung function. Some of the key indications in this therapy area ...

$ 4,995.00

Read More

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

01 Aug 2016  |  Published by:  GBI Research
SummaryDiabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. This chronic hyperglycemia is associated with long-term damage, dy...

$ 4,995.00

Read More

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

26 Jul 2016  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for therapies for rheumatoid arthritis reached $19.0 billion in 2014. The market is expected to reach nearly $21.3 billion by 2020 from $19.9 billion in 2015, increasing at a compound annual growth rate (CAGR) of 1.3% from 2015 to 2020. This report provides: -An overvie...

$ 6,650.00

Read More
Total 93 records.